Delivery Order SPE2DX22D0010-SPE2D824FNN39

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $3.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $6,672.25, is a firm fixed price delivery order for 4,564,082,819 units of Oxymorphone Hydrochloride Extended-Release Tablets 40mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order, valued at $7,547.36, is for the supply of Oxymorphone Hydrochloride Extended-Release Tablets, 20mg. The contract is a firm-fixed-price delivery order with an ultimate completion date of August 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts by the DLA and other...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,938.49 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 24, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,417.79, is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of February 4, 2025. The contract is a firm fixed-price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,824.02 firm fixed-price delivery order is for the supply of Oxymorphone HCL ER Tablets, 7.5 mg, with a period of performance through February 10, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $6,729.58 Firm Fixed Price Delivery Order is for the supply of 30mg Oxymorphone Hydrochloride Extended Release Tablets, a prescription medication. The award is associated with Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,862.76, is for the delivery of oxymorphone hydrochloride extended-release tablets, a prescription pain medication. The contract is a firm-fixed price delivery order with a completion date of July 25, 2024. The award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award, valued at $7,904.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of 4566006917 - Oxymorphone HCL ER Tabs 20mg, a prescription pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is October 3, 2024. The contract was awarded on October 2, 2024 and does...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,107.93 firm fixed price contract is for the delivery of oxymorphone hydrochloride extended-release tablets with a completion date of May 6, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FNN39
    Delivery Order

This federal contract award, valued at $3,850.93, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564965170 - Oxymorphone Hydrochloride Extended-Release Tablets, 15 mg. The contract has a period of performance through June 24, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, is not subject to any set-aside requirements for this award. In addition to this specific contract, Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to the Department of Defense worldwide.

Generated 9/20/24, 9:13 AM